Michael  Witcher

Assistant Professor


Jewish General Hospital
Room E-444
3755 Côte Ste Catherine Road
Montreal, QC H3T 1E2

Telephone: 514-340-8222, x3363
E-mail: michael.witcher@mcgill.ca

Education: Ph.D., McGill University; M.Sc., B.Sc., Memorial Univeristy of Newfoundland

Research Focus: Epigenetic silencing of tumor suppressors in breast cancer. Drugging the epigenome as an approach to fight cancer.

Recent Publications:

Tiejun Zhao, Qiang Sun, Sonia V. del Rincon, Amanda Lovato, and Michael Witcher.
Gallotannin imposes S phase arrest and effectively treats triple-negative breast cancer using in vivo models. Submitted under review.

Lovato A, Panaschi L, Witcher M.
Is there an epigenetic component underlying the resistance of triple-negative breast cancers to PARP inhibitors? Frontiers in Pharmacology of anti-cancer drugs. 2012;3:202. doi: 10.3389/fphar.2012.00202.

Balakrishnan SK, Witcher M, Berggren TW, Emerson BM.
Functional and Molecular Characterization of the Role of CTCF in Human Embryonic Stem Cell Biology. PLoS One. 2012;7(8):e42424.